Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 985.50
+34.95 (3.68%)
At close: Feb 9, 2026
Laurus Labs Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 67,216 | 55,540 | 50,408 | 60,406 | 49,356 | 48,135 | |
Revenue Growth (YoY) | 27.46% | 10.18% | -16.55% | 22.39% | 2.54% | 69.98% |
Cost of Revenue | 28,888 | 25,887 | 25,398 | 28,598 | 22,488 | 21,990 |
Gross Profit | 38,329 | 29,653 | 25,010 | 31,808 | 26,868 | 26,145 |
Selling, General & Admin | 8,546 | 7,369 | 6,529 | 5,995 | 5,043 | 4,380 |
Other Operating Expenses | 12,920 | 11,731 | 10,687 | 9,625 | 7,559 | 6,208 |
Operating Expenses | 26,150 | 23,401 | 21,062 | 18,861 | 15,117 | 12,638 |
Operating Income | 12,178 | 6,252 | 3,949 | 12,947 | 11,751 | 13,507 |
Interest Expense | -1,773 | -2,066 | -1,718 | -1,229 | -757.6 | -561.2 |
Interest & Investment Income | 151.7 | 151.7 | 56.1 | 45.6 | 17.2 | 13.1 |
Earnings From Equity Investments | -9.9 | 39.3 | -59.4 | -32.1 | -2 | - |
Currency Exchange Gain (Loss) | -5.1 | -5.1 | 4.2 | -475 | 0.2 | 159.3 |
Other Non Operating Income (Expenses) | 206 | -60.2 | -78.9 | -197 | -159.8 | -100.5 |
EBT Excluding Unusual Items | 10,748 | 4,312 | 2,153 | 11,059 | 10,849 | 13,017 |
Gain (Loss) on Sale of Assets | 570.5 | 570.5 | -19.3 | -2.1 | -12.1 | -6.1 |
Pretax Income | 11,319 | 4,882 | 2,304 | 11,057 | 10,837 | 13,011 |
Income Tax Expense | 2,910 | 1,299 | 681.5 | 3,123 | 2,514 | 3,173 |
Earnings From Continuing Operations | 8,408 | 3,583 | 1,623 | 7,934 | 8,322 | 9,838 |
Minority Interest in Earnings | 25 | -0.2 | -17.2 | -33.2 | -47.1 | -2.4 |
Net Income | 8,433 | 3,583 | 1,606 | 7,901 | 8,275 | 9,836 |
Net Income to Common | 8,433 | 3,583 | 1,606 | 7,901 | 8,275 | 9,836 |
Net Income Growth | 321.11% | 123.18% | -79.68% | -4.52% | -15.87% | 285.31% |
Shares Outstanding (Basic) | 539 | 539 | 539 | 538 | 537 | 536 |
Shares Outstanding (Diluted) | 540 | 540 | 540 | 540 | 539 | 538 |
Shares Change (YoY) | -0.00% | -0.01% | 0.01% | 0.08% | 0.19% | 0.88% |
EPS (Basic) | 15.64 | 6.65 | 2.98 | 14.69 | 15.42 | 18.36 |
EPS (Diluted) | 15.61 | 6.64 | 2.97 | 14.64 | 15.35 | 18.28 |
EPS Growth | 321.68% | 123.57% | -79.71% | -4.63% | -16.03% | 281.99% |
Free Cash Flow | - | -393.5 | -126.2 | 37.4 | 342.6 | 442.3 |
Free Cash Flow Per Share | - | -0.73 | -0.23 | 0.07 | 0.64 | 0.82 |
Dividend Per Share | 1.600 | 1.200 | 0.800 | 2.000 | 2.000 | 2.000 |
Dividend Growth | 100.00% | 50.00% | -60.00% | - | - | 300.00% |
Gross Margin | 57.02% | 53.39% | 49.62% | 52.66% | 54.44% | 54.32% |
Operating Margin | 18.12% | 11.26% | 7.83% | 21.43% | 23.81% | 28.06% |
Profit Margin | 12.55% | 6.45% | 3.19% | 13.08% | 16.77% | 20.43% |
Free Cash Flow Margin | - | -0.71% | -0.25% | 0.06% | 0.69% | 0.92% |
EBITDA | 16,576 | 10,342 | 7,629 | 16,059 | 14,177 | 15,498 |
EBITDA Margin | 24.66% | 18.62% | 15.13% | 26.59% | 28.72% | 32.20% |
D&A For EBITDA | 4,398 | 4,090 | 3,680 | 3,113 | 2,427 | 1,991 |
EBIT | 12,178 | 6,252 | 3,949 | 12,947 | 11,751 | 13,507 |
EBIT Margin | 18.12% | 11.26% | 7.83% | 21.43% | 23.81% | 28.06% |
Effective Tax Rate | 25.71% | 26.60% | 29.58% | 28.24% | 23.20% | 24.39% |
Revenue as Reported | 68,082 | 56,139 | 50,616 | 60,420 | 49,492 | 48,359 |
Advertising Expenses | - | 137.8 | 106.8 | 166 | 4.9 | 18.9 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.